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Abstract
Background Today, no proven significant association was
detected between sun-exposed vitiliginous patches and non-
melanotic skin cancers. In fact, the occurrence of a basal
cell carcinoma (BCC) in vitiliginous patches seems to be
extremely rare.
Case report We present a case of a 33-year-old female
patient suffering from BCC in a vitiliginous patch on the
cheek. This is the first report of the occurrence of a
sclerodermiform type of BCC in a vitiliginous macula.
Conclusion Our case report challenges the long-standing
belief that the occurrence of BCC in vitiligo is nearly
impossible. However, even if this association is apparently
fortuitous, our report contributes to the awareness of the
risk of BCC in young patients with vitiligo.
Keywords Vitiligo.Basal cell carcinoma.Non-melanotic
skin cancer.Split-thickness skin graft
Introduction
The possible association of vitiligo and non-melanotic skin
cancers (NMSC) has been discussed controversially and no
consensus had been achieved in the literature as to whether this
association is significant or fortuitous. Few reports of occur-
rences of squamous cell carcinoma in patients with generalized
vitiligo or after long-term psoralen ultraviolet-A therapy for
vitiligo had been published previously [1–3]; basal cell
carcinoma (BCC) in vitiliginous patches seems to be rare.
Hence, reports could be found in recent literature only
sporadically [4]. We present a case report of a young female
suffering from BCC appearing on vitiligo macula in the cheek
region and a review of the recent literature. To our knowledge,
this is the first report of a sclerodermiform type of BCC
associated with vitiligo. It is also important to note the young
age of the patient.
Case report
A 33-year-old Caucasian female was referred from the
department of dermatology to the oral and maxillofacial
department at our clinic centre. When the patient first
presented, a 5×3.5-cm, erythematous, partly verrucous,
partly plain and not well-circumscribed lesion located on a
6×4.5 depigmented vitiliginous patch on the left cheek was
found (Fig. 1). This lesion had been present for 5 years and
the patient had sought no treatment. No further depig-
mented patches on the body surface could be detected. The
patient denied excessive sun exposure or sunburns in the
past. A biopsy was performed and histological evaluation
revealed a sclerodermiform BCC (Fig. 2). The total
resection of the tumour included the resection of the whole
vitiligo patch. Histological evaluation showed complete
excision of the tumour with an infiltration depth of 7 mm
and circumferential and basal security borders of 3 mm.
Following clarification about plastic reconstruction possi-
bilities, the patient preferred a split-thickness skin graft
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resection, the defect was temporarily covered with artificial
skin substitute for 14 days until the tissue had nearly reached
the level of the surrounding skin. In a second step, the defect
was closed with a 4-mm split-thickness skin graft from the right
femoral region. As expected, a difference in colour occurred
towards the surrounding tissue after 5 weeks (Fig. 3). However,
the patient was completely satisfied with the outcome.
Discussion
Ultraviolet radiation is a well-known risk factor in
Caucasians for developing BCC with a latency period of
decades. Considering that patients with vitiligo often have
no protective pigment in sun-exposed vitiliginous skin
areas, it would be expected that these patients have an
increased risk for early photodamage and development of
NMSC. Until now, however, there was no evidence found
for sun-related damage in these patients histologically or by
dermatoscopy. This was despite a significant number of
cases with a history of sunburns in early childhood and
continuous accumulation of millimolar epidermal perox-
ide [2]. Interestingly, this lack of sun-related damages
could be linked to an overexpression of functional wild-
type tumour suppressor gene p53 in vitiligo patches. This
proposes that there is a protective function of this tumour
suppressor gene in vitiligo, which could avoid lasting
photodamage and the development of NMSC [5]. How-
ever, these findings are in contradiction to the occurrences
of squamous cell carcinoma on a localized lesion of
vitiligo, which has never been exposed to sunlight, e.g., on
the genital mucous membrane [6], and the development of
BCC in our case report.
Generally, in patients with vitiligo, it has to be
determined whether the skin cancers were located on
vitiliginous or normal-appearing skin. Hexel et al. [7]
reported about six Caucasian patients with NMSC and
vitiligo on sun-exposed sites. In only two patients NMSC
occurred on the skin of the face. In only one of these
patients BCC occurred on vitiliginous skin of the nasolabial
fold and in the other patient in the normal preauricular skin.
Both patients were male and older than 75 years. In this
study, the incidence of NMSC among Caucasian patients
Fig. 1 Persistent non-healing 5×3.5 cm, erythematous, partly
verrucous, partly plain irregular lesion located on a 6×4.5 vitiliginous
macula on the left cheek of a young female
Fig. 2 Histological findings of a sclerodermiform type of basal cell
carcinoma in a vitiliginous macula. Characteristic basaloid tumour cell
clusters in the epidermis, typical peripheral palisading of nuclei,
variable infiltrate of lymphocytes and plasma cells, and missing
melanocytes (hematoxylin–eosin stain, ×10 magnification)
Fig. 3 Post- operative finding 5 weeks after reconstruction of the
cheek with split-thickness skin graft. As expected, difference in colour
occurred towards the surrounding tissue
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US populations. Results suggest that there may be an
increased or equal risk of NMSC in patients with vitiligo.
However, significant differences could not be obtained in
comparison to patients without vitiligo. In our case report,
the patient represented Fitzpatrick skin phototype II [8] and
was therefore more susceptible to skin cancer. Although the
patient was young, the localization in a vitiliginous patch
and the low sun exposure are in contrast to the usual risk
factors for BCC. Obviously, other factors, such as sponta-
neous mutations on the genetic level [9], might play a more
important role. Further studies with large cohorts providing
histological as well as immunohistochemical findings are
warranted to enlighten the relationship between vitiligo and
NMSC. Our case report contributes to the awareness of the
risk of developing BCC even in young patients with vitiligo.
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